
To improve the lives of people with or at risk for End Stage Renal Disease by promoting and advancing quality of care.
01/12/2010: Rapamune (sirolimus): Drug Monitoring Recommendations
10/16/2009: Dexferrum (Iron Dextran Injection) - Labeling Change
10/07/2009: Philips Heartstart Fr2+ Automated External Defibrillators - Recall